Cortesi, Paolo Angelo, Damiano Paolicelli, Marco Capobianco, Paolo Cozzolino, and Lorenzo Giovanni Mantovani. 2019. “The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis”. Farmeconomia. Health Economics and Therapeutic Pathways 20 (1). https://doi.org/10.7175/fe.v20i1.1435.